Oak Ridge Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
12,306
-616
| -5% | -$64.3K | 0.09% | 107 |
|
|
2025
Q1 | $1.51M | Sell |
12,922
-23
| -0.2% | -$2.68K | 0.13% | 102 |
|
|
2024
Q4 | $1.1M | Sell |
12,945
-472
| -4% | -$39.9K | 0.09% | 113 |
|
|
2024
Q3 | $1.21M | Sell |
13,417
-519
| -4% | -$46.6K | 0.11% | 104 |
|
|
2024
Q2 | $1.12M | Sell |
13,936
-1,994
| -13% | -$161K | 0.11% | 108 |
|
|
2024
Q1 | $1.27M | Buy |
15,930
+413
| +3% | +$33K | 0.13% | 110 |
|
|
2023
Q4 | $1.23M | Sell |
15,517
-2,524
| -14% | -$201K | 0.14% | 111 |
|
|
2023
Q3 | $1.26M | Buy |
18,041
+5,014
| +38% | +$350K | 0.16% | 109 |
|
|
2023
Q2 | $936K | Buy |
+13,027
| New | +$936K | 0.12% | 125 |
|
|
2021
Q3 | – | Sell |
-36,467
| Closed | -$2.46M | – | 174 |
|
|
2021
Q2 | $2.46M | Sell |
36,467
-3,626
| -9% | -$245K | 0.21% | 112 |
|
|
2021
Q1 | $2.27M | Sell |
40,093
-779
| -2% | -$44.1K | 0.21% | 111 |
|
|
2020
Q4 | $3.33M | Sell |
40,872
-9,486
| -19% | -$773K | 0.29% | 105 |
|
|
2020
Q3 | $3.59M | Buy |
50,358
+13,892
| +38% | +$990K | 0.28% | 106 |
|
|
2020
Q2 | $3M | Sell |
36,466
-3,163
| -8% | -$260K | 0.25% | 107 |
|
|
2020
Q1 | $2.33M | Buy |
+39,629
| New | +$2.33M | 0.24% | 103 |
|